Bill Text: HI HB2096 | 2020 | Regular Session | Introduced
Bill Title: Relating To Health.
Spectrum: Strong Partisan Bill (Democrat 13-1)
Status: (Introduced - Dead) 2020-02-07 - Passed Second Reading as amended in HD 1 and referred to the committee(s) on CPC/JUD with none voting aye with reservations; none voting no (0) and Representative(s) McDermott, Yamashita excused (2). [HB2096 Detail]
Download: Hawaii-2020-HB2096-Introduced.html
|
HOUSE OF REPRESENTATIVES |
H.B. NO. |
2096 |
|
THIRTIETH LEGISLATURE, 2020 |
|
|
|
STATE OF HAWAII |
|
|
|
|
|
|
|
|
||
|
|
||
A BILL FOR AN ACT
RELATING TO HEALTH.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. Chapter 328, Hawaii Revised Statutes, is amended by adding a new section to be appropriately designated and to read as follows:
"§328- Cannabidiol
products; product testing. (a) All products containing cannabidiol or marketed
or sold as containing cannabidiol shall only be sold in the State if:
(1) The product has
a certificate of analysis prepared by an independent testing laboratory that
states the product does not contain contaminants unsafe for human consumption
and contains a total delta-9-tetrahydrocannabinol concentration that does not
exceed 0.3 per cent on a dry-weight basis pursuant to the testing of a random
sample of the batch; and
(2) The product is
sold or distributed in packaging that includes:
(A) A
scannable barcode or quick reference code linked to the certificate of analysis
of the product by an independent testing laboratory;
(B) The
batch number;
(C) The
internet address of a website where batch information may be obtained;
(D) The
expiration date;
(E) The
number of milligrams of cannabidiol;
(F) A
statement that the product contains a total delta-9-tetrahydrocannabinol
concentration that does not exceed 0.3 per cent on a dry-weight basis; and
(G) A
statement certifying that the product is free from contaminants that are unsafe
for human consumption.
(b)
For purposes of this section, "independent testing
laboratory" means a laboratory that:
(1) Does not have a
direct or indirect interest in the entity whose product is being tested;
(2) Does not have a
direct or indirect interest in a facility that cultivates, distributes,
dispenses, or sells cannabidiol, hemp, or hemp extract in the State or in
another jurisdiction; cultivates, processes, distributes, or sells marijuana,
as defined in sections 329-1 and 712-1240; or holds a medical cannabis
dispensary license pursuant to chapter 329D; and
(3) Is accredited by a third-party accrediting body as a competent laboratory pursuant to ISO/IEC 17025 of the International Organization for Standardization."
SECTION 2. New statutory material is underscored.
SECTION 3. This Act shall take effect on July 1, 2020.
|
INTRODUCED BY: |
_____________________________ |
|
|
|
Report Title:
Cannabidiol Products; Product Safety; Packaging Requirements
Description:
Requires all cannabidiol products sold in the State to be tested by an independent testing laboratory for contaminants unsafe for human consumption and THC levels. Requires the packaging on all cannabidiol products to contain information concerning THC levels and other product safety requirements.
The summary description
of legislation appearing on this page is for informational purposes only and is
not legislation or evidence of legislative intent.
